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AbstrAct
Objective: The study aims to present the medication classes involved in medication errors occurred at an Intensive Care Unit 
and to identify which are classified as high-alert medication classes. Methods: The population was composed of the documents 
of occurrence of errors contained in a database created for a previous investigation. We performed a secondary analysis of the 
available information. Results: Overall, 305 events were identified, with an average rate of 6.9 events per patient. Seventy-three 
medications were found, distributed among 33 classes according to their predominant action, the most frequent of which were: 
antibiotics (25.2%), gastric acid reducers (19.0%) and antihypertensive drugs (9.2%). Thirty-seven (12.1%) events involving 
high-alert medication classes were identified, corresponding to five classes, among which venous anesthetics predominated 
(43.3%). Conclusion: These drug types are frequently used at intensive care units and should be accurately monitored, as they 
can cause further damage when incorrectly used.
Keywords: Medication errors; Medication systems; Intensive care units; Quality of health care.
resumo
Este estudo objetivou apresentar as classes dos medicamentos envolvidos nos erros de medicação ocorridos em Unidade de 
Terapia Intensiva e identificar aqueles que são classificados como medicamentos de alta vigilância. Métodos: A população 
foi composta pelas fichas de ocorrências de erros que constavam em um banco de dados de uma investigação prévia. Foi 
realizada uma análise secundária das informações disponíveis Resultados: Foram identificados 305 eventos, obtendo-se 
média de 6,9 ocorrências por paciente. Verificaram-se 73 medicamentos distribuídos em 33 classes de acordo com sua ação 
predominante, sendo os mais frequentes: antibióticos (25,2%), redutores de acidez gástrica (19,0%) e anti-hipertensivos (9,2%). 
Foram identificadas 37 (12,1%) ocorrências com medicamentos de alta vigilância, que corresponderam às cinco classes, e a 
dos anestésicos venosos foi predominante (43,3%). Conclusão: Estes tipos de medicamentos são usados frequentemente nas 
unidades intensivas e devem ter um monitoramento acurado, uma vez que podem causar danos maiores se o seu uso for incorreto.
Palavras-chave: Erros de medicação; Sistema de medicação; Unidade de terapia intensiva; Qualidade da assistência à saúde.
resumen
Objetivo: Este estudio presenta las clases de los medicamentos involucrados en los errores de medicación e identifica 
aquellos que son clasificados como medicamentos de alto riesgo. Métodos: La población fue compuesta de los documentos 
de las ocurrencias de errores contenidos en una base de datos de una investigación previa. Se realizó un análisis secundario 
de la información disponible. Resultados: Fueron identificados 305 eventos, resultando en un promedio de 6,9 eventos por 
paciente. Fueron verificados 73 medicamentos, distribuidos en 33 clases de acuerdo con su acción predominante, siendo las 
más frecuentes: antibióticos (25,2%), reductores de acidez gástrica (19,0%) y antihipertensivos (9,2%). Fueron identificadas 
37 (12,1%) ocurrencias con medicamentos de alto riesgo, correspondientes a cinco clases. La incidencia con anestésicos 
venosos fue predominante (43,3%). Conclusión: Estos tipos de medicamentos son de uso frecuente en las Unidades de Terapia 
Intensiva y su monitoreo debe ser adecuado, ya que pueden causar daños mayores cuando utilizados de manera incorrecta.
Palabras-clave: Errores de medicación; Sistemas de medicación; Unidades de cuidados intensivos; Calidad de la atención de salud.
EEAN.edu.br
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INTRODUCTION
The concept of system refers to the disposition of the parts or 
elements of a whole, coordinated with each other and functioning 
as an organized structure. The system allows subsystems or 
processes, which have their own functions and objectives and 
affect the behavior of the set. If there is an action performed by 
one part, there is necessarily a reaction from the others1.
The medication system is viewed as complex and dynamic 
and it encompasses several stages, such as: selection and 
obtention of the medication; prescription; preparation and 
dispensation; administration of medications; and monitoring of 
the patient2.
The design of a system should be flexible and adequate 
to the reality of each institution, region or country, judging by 
the structural and procedural conditions in which it is included. 
However, independently of the subsystems that constitute it or of 
the professionals who act in it, the path should be safe, ensuring 
that the patient receives the drug therapy in an effective, efficient, 
efficacious and optimized way, in compliance with specific 
legislations and supported by quality standards1,2.
Administering drugs to patients at healthcare institutions is 
a complex process, with multiple steps that depend on a series 
of decisions and actions that are interrelated. Nevertheless, not 
always is the system sufficiently safe, and errors occur that may 
or may not cause damage to the patient. These errors, which 
are called medication errors (ME), are considered preventable 
adverse events3.
There are diverse reasons for the occurrence of ME, 
ranging from lack of knowledge about the medications, lack 
of information on the patient, memory slips and lapses, trans-
cription errors, failure in the verification of the administered 
dose, defective infusion pumps and inadequate monitoring of 
the patient, to inappropriate storage of the medications or lack 
of labeling with alerts for use, among others2-4. Thus, ME may 
occur at any part of the medication system and may involve 
any of the countless medications that are available, including 
those classified as high-alert medications.
High-alert medications (HAM), also known as high-risk 
or potentially dangerous medications, are those with higher 
potential to cause severe or even fatal damage when an error 
occurs during their utilization. Although occurrences involving this 
type of medication are less common, the consequences to the 
user can be more devastating5. The report of the North American 
system MedMarx®, used for ME notification, shows that, in the 
period from 2006 to 2008, occurrences with HAM corresponded 
to approximately 7% of the 443,683 reported errors6.
Studies have indicated that there is a higher frequency of ME 
at Intensive Care Units (ICUs), with more severe implications to 
patients, compared to clinical or surgical hospitalization units2. The 
reason is that ICUs are complex environments in which patients 
present different severity levels, are submitted to countless 
procedures and receive a great variety of drugs, including HAM.
However, studies have shown that 7% of the ME with HAM 
occurred at ICUs6 and also that the nurses responsible for 
administering these drugs had insufficient knowledge about 
them7. Thus, studying them sheds light on the reasons why they 
occur and their analysis enables to prevent errors.
Therefore, bearing in mind that deviations from the quality 
standard of the medication system may cause damage to the 
patient and that the nursing team is in charge of the medication 
administration subsystem, the present study aims to present 
the medication classes involved in ME at an ICU and to identify 
those which are classified as HAM.
METHOD
This is a descriptive, quantitative study whose population 
was composed of the documents that registered the occurrences 
of ME, which were part of a database of a previous investigation 
called "Erros de medicação em unidade de terapia intensiva 
geral de um hospital universitário do município de São Paulo" 
(Medication errors at a general intensive care unit of a university 
hospital in the city of São Paulo), approved by the Committee for 
Ethics in Research of UNIFESP under number 0449/052.
The study whose data originated this one was descrip-
tive/exploratory and quantitative. It was carried out at a general 
ICU of 16 beds, during 30 days, in the year of 2006. The strategy 
for data collection was spontaneous notification, interview with the 
professionals involved in the provision of care and verification of the 
medical prescriptions of the 44 patients who were hospitalized at 
the period. The documents that registered the occurrences of ME 
contained information related to the population (characterization 
of the subjects and reasons for hospitalization), to the medication 
(prescribed drugs, classes of drugs and HAM involved in ME), 
occurrence (strategy of error verification, shift of the occurrence and 
the professional who notified it), types of errors, probable causes, 
and consequences to the patient2.
For the present study, all the documents containing regis-
tered occurrences were revised and a secondary analysis of 
the data4 was performed, allowing to investigate the variables 
related to medication.
To identify the medication classes according to the predomi-
nant action, the adopted reference was the pharmacotherapeutic 
guide of the Universidade Federal de São Paulo (UNIFESP), 
after the names (generic or brand) of the medication involved 
in ME were noted down8.
The framework of the Institute for Safe Medication Practices 
(ISMP) was used to identify the HAM5. This institute is a North 
American non-governmental organization for the education of 
healthcare professionals and of consumers concerning safe 
medication practices. Its representativeness has been formalized 
in Brazil since 2009. In addition, it maintains a list of HAM based 
on literature findings, experts' inputs and error reports submitted 
to the "Medication errors reporting program" of the institute itself9. 
The most recent list was reviewed by the members of the clinical 
staff and of the advisory board of the ISMP, and also by safety 
experts in the United States of America. The list was published 
on the institute's website in February 2012 and it presents 22 
classes/categories of drugs and 10 specific medications5.
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RESULTS
The total number of documents with registers of occurrences 
was 305, and the obtained mean was 6.9 (± 6.8; median = 5) 
occurrences per patient. The daily mean of 14.6 prescribed 
medications per patient was found.
The number of medications involved in the occurrences 
was 73, and they were grouped according to their predominant 
action8, distributed among 33 classes, as presented on Table 1.
Of the total number of medications involved in ME, the class 
of antibiotics totaled 77 (25.2%) events, followed by the class 
of gastric acid reducers (58, or 19.0%) and by antihypertensive 
drugs (29, or 9.2%). Together, the three classes represent the 
majority (53.4%) of the findings. It was also verified a frequency 
of 16 (5.2%) events with venous anesthetics, 14 (4.6%) with 
antiemetics, 13 (4.3%) with electrolyte replenishers and 10 
(3.3%) with anticoagulants, representing, together with the 
above-mentioned drugs, more than 70% of all the occurrences. 
These are drugs that are routinely used at ICUs, fundamental to 
the patients' therapeutic needs.
Of the 33 classes of medications grouped on Table 1, five 
are included in the HAM framework of the ISPM5, as presented 
in chart 1.
It was found that 37 (12.1%) occurrences were related to 
HAM. The class of venous anesthetics predominated, corres-
ponding to 16 (43.3%), as shown by Table 2. All the medication 
classes deserve special attention during all the stages: prescrip-
tion, dispensation, administration or patient monitoring.
DISCUSSION
The studied institution assists patients in severe health 
conditions, with varied pathologies and who are submitted to 
countless procedures and interventions. However, it was verified 
that the proportion of ME per patient, when compared to other ICU 
investigations, is considered very high. In a study carried out at a 
teaching hospital in the city of São Paulo, based on notifications 
of events, 44.1% of occurrences with medications, within a total 
of 103 occurrences, which affected 103 patients hospitalized at 
the ICU, corresponding to 0.4 ME per patient10.
Nevertheless, the amount of events should be discussed in 
light of the strategies to detect errors adopted in the studies. In 
the present research, the documents with registered occurrences 
considered the information derived from three strategies to 
detect errors, while in the literature findings, the analysis was 
based on event notification reports, whose ME are known to be 
undernotified11. In addition, it is believed that one single technical 
detection modality is not sufficient to perform adequate samplings 
within such a complex system as that of medication. Therefore, 
it is believed that many detection forms can be utilized, with 
the objective of providing reliable data and allowing to perform 
a better analysis of the situation, such as non-participant 
Table 1. Distribution of the occurrences according to the 
medication’s predominant action. São Paulo, 2007
Class n %
% 
cumulative
Antibiotic 77 25.2 25.2
Gastric acid reducer 58 19.0 44.2
Antihypertensive 28 9.2 53.4
Venous anesthetic (opiates and 
non-opiates)
16 5.2 58.6
Antiemetic 14 4.6 63.2
Electrolyte replenisher 13 4.3 67.5
Anticoagulant 10 3.3 70.8
Narcotic analgesic 8 2.6 73.4
Diuretic 7 2.3 75.7
Neuroleptic 7 2.3 78.0
Anti-inflammatory hormone 5 1.6 79.6
Antiparasitic 5 1.6 81.2
Thyroid hormone 5 1.6 82.8
Vitamins 5 1.6 84.4
Analgesic, antipyretic, 
non-hormonal anti-inflammatory
4 1.3 85.7
Anti-infective and 
anti-inflammatory, ophthalmic use
4 1.3 87.0
Cardiotonic 4 1.3 88.3
Hypnotic/sedative/anxiolytic 4 1.3 89.6
Antagonists of neuromuscular 
blockers
3 1.0 90.6
Antiarrhythmic 3 1.0 91.6
Bronchodilator 3 1.0 92.6
Hypocholesterolemic 3 1.0 93.6
Coronary vasodilator 3 1.0 94.6
Antiplatelet 2 0.7 95.3
Anticonvulsant 2 0.7 96.0
Antidepressant 2 0.7 96.7
Antifungal 2 0.7 97.4
Antidiabetic 2 0.7 98.1
Immunosuppressive 2 0.7 98.8
Nasal decongestant 1 0.3 99.1
Blood volume expander 1 0.3 99.4
Vasoconstrictor 1 0.3 99.7
Cerebral vasodilator 1 0.3 100.0
Total 305
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Chart 1. Correspondence between the medication classes involved in the medication errors
Medication class according to the predominant action Medication class and specific high-alert medications
Antihypertensive Adrenergic antagonists
Venous anesthetic (opiate and non-opiate) Anesthetic agents, general, inhalational and intravenous
Anticoagulant Antithrombotic agents, including anticoagulants
Narcotic analgesic Narcotics and opiates, intravenous, transdermal and oral
Antidiabetic Insulin, subcutaneous and intravenous
Guia Farmacoterapêutico8; ISMP’s List of High-Alert Medications5.
Table 2. Distribution of the occurrences according to 
high-alert medication classes and examples of products. 
São Paulo, 2007
Class n %
Venous anesthetic (Fentanyl; 
Propofol, Midazolam)
16 43.3
Anticoagulant (Heparin) 10 27.0
Narcotic analgesic (morphine 
sulfate, tramadol hydrochloride)
8 21.6
Antidiabetic (insulin) 2 5.4
Antihypertensive (Propranolol) 1 2.7
Total 37 100.0
observation, analysis of the patients' clinical parameters, 
return of medications to the pharmacy, trigger tool (tracking 
information in the patient's medical record, searching for signs 
of possible adverse events), safety patrols and interventions of 
the pharmacist working at the ICU4,7,12,13.
Patients hospitalized at ICUs usually receive a higher 
number of drugs when compared to those hospitalized at 
other units13. In the studied ICU, the mean was 14.6 prescribed 
medications, per day, per patient. This finding confirms the 
complexity and severity of the patients hospitalized in this type 
of unit. The drug therapy proposed for health recovery and life 
maintenance accompanies the quick oscillations - between 
normality and abnormality - that derive from organic instability, 
which requires immediate modification of the medications, with 
efficient decision-making. These situations of temporal pressure 
favor the occurrence of adverse events and, when associated 
with the severity of the patients' condition, they may cause 
irreparable damage to them, thus requiring maximum attention 
on the part of the professionals10,13. Therefore, the recognition 
that such events occur shows that an analysis of their causes 
is extremely important, as detection of deviations from quality 
standards during the care process is what enables preventive 
attitudes, with the implementation of strategies that ensure the 
quality of care4.
The administration of a high number of medications per 
patient reveals the importance of monitoring patients regarding 
their response to the adopted therapy. This aspect includes 
recognizing adverse reactions and detecting errors that are the 
responsibility of all, and this should encompass, whenever pos-
sible, patients and their relatives. It should also be emphasized 
that the professionals must pay attention to the interactions that 
can occur between medications and nutrients or environmental 
chemicals, and warn patients of possible undesired responses 
concerning the therapy12,14.
The documents that register the occurrences derived from 
an investigation carried out at a general ICU; thus, a high amount 
of classes of prescribed medications was expected, in view of 
the patients' clinical conditions. However, a high number of ME, 
divided into 33 classes, was verified, and the class of antibiotics 
predominated.
Therapy with antibiotics is indicated to combat pathogenic 
microorganisms and its choice is based on sensitivity testing of 
the pathogen and on the drug's potential toxicity to the patient. 
Whenever possible, the selection of antibiotics should be 
preceded by culture and sensitivity testing, and many times, 
their indication is prophylactic and based on the assessment 
of the risk factors that may contribute to the development of 
infections, such as: extensive surgical procedures, obesity, 
previous conditions (diabetes, chronic obstructive pulmonary 
disease), use of immunosuppressive drugs, malnutrition and 
extreme age groups (children and elderly individuals). However, 
the indication is the result of the physician's clinical judgment, 
and its monitoring depends on the specific knowledge of the 
multiprofessional team at all the stages of the treatment14.
The characteristics of the units at which patients are hos-
pitalized should be observed, as some medications are more 
commonly used in certain areas or specialties than others. For 
example, a higher number of occurrences with cardiovascular 
drugs is expected to be found at clinical ICUs compared to 
surgical ICUs.
The present study detected that the majority of ME are 
related to the classes of antibiotics, gastric acid reducers and 
antihypertensive drugs. A North American study that investigated 
the frequency of adverse events with medications according to 
their class found a higher frequency of errors related to cardio-
vascular drugs (17%), antibiotics (15%) and sedatives (14%)15.
Thus, when the profile of the hospitalized patient is taken 
into account - severe and unstable -, it is worrisome to verify the 
high number of medication classes involved in the occurrences 
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of ME. Therefore, it is important to emphasize that the causes of 
the errors must be analyzed and the proposals for improvement, 
implemented, in order to ensure the adequate functioning of the 
medication system4,12.
The HAM should be accurately monitored at any hospital, as 
they can cause further damage when their use is incorrect9. In this 
study, in particular, they corresponded to 37 (12.1%) occurrences, 
and the medications that were classified as venous anesthetics 
predominated.
The use of this type of medication is frequent at ICUs to 
sedate patients, due to their very clinical condition and to invasive 
and painful procedures and exams, which bring discomfort and 
anxiety. Sedation is employed in a controlled manner to reduce 
the level of consciousness. There are many levels of sedation, 
ranging from minimal sedation to general anesthesia, which differ 
from one another by the patient's capacity to maintain protective 
reflexes and patent airways. As it is difficult to accurately define 
the limits that separate the different sedation levels, the patient 
may transit quickly to the deeper ones. This aspect shows the 
importance of the professionals who prescribe and administer 
HAM at ICUs. Both the medical and nursing teams should be 
qualified to know and handle medications, to monitor the different 
levels of sedation, to evaluate the patients' responses continually, 
and to recognize adverse reactions and the interaction of drugs16.
A study about the incidence of errors with HAM, based on the 
North American computer system, identified that 45% of these 
events involved insulin and 21%, heparin and warfarin in equal 
proportions, revealing the need of a rigorous monitoring in 23% 
of the patients to prevent damage6.
Studies have warned of the need to monitor the HAM used in 
diverse areas of a hospital, especially in units like the pediatric or 
oncology ones. They mention that the most common type of error 
is that of "wrong dose", and report on the danger of the patient 
receiving a dose, for example, 10 times higher than the indicated 
one - this may even result in the patient's death7,15.
As a proposal for the safety of the medication system, focusing 
specifically on HAM, there are procedures that can be adopted 
to prevent ME with these drugs, such as: having a list of HAM, 
which should be broadly disseminated; implementing guidelines 
to the prescription, dispensation, preparation, administration and 
storage of these drugs; labeling the medications with different 
colors or alert signs on the package; adopting double-check in 
drug dispensation, preparation and administration; restricting 
the number of presentations and concentrations at institutions; 
banning concentrated electrolyte solutions, specifically injectable 
potassium chloride solutions, from infirmaries and outpatient 
clinics; providing a continuing education program about medi-
cations to the professionals involved; managing, with specific 
indicators, ME with HAM; implementing a specific program of 
safety of patients hospitalized at ICUs concerning the use of 
medications5,9,13,14.
The adoption of the double-check system is recommended 
for safe practices at any stage of the medication system, mainly 
when medications that may bring greater risk are involved. This 
working process involves two persons in the execution of the 
activity. Traditionally employed in the industry, its function is to 
minimize the chances of errors or mistakes when a product 
that needs to have full operation is to be launched. When this 
methodology is applied to the healthcare area, it can ensure that 
procedures which are known to have critical points receive greater 
attention from professionals. For its execution, the agents that will 
be part of the process must be identified, as well as the steps 
that must be followed and the place for documenting the action17.
The area of information technology has conducted rese-
arch in order to provide subsidies for the performance of the 
double-check procedure when there are problematic working 
conditions, like interruptions and distractions or a busy clinical 
environment. The computer program iDoseCheck helps profes-
sionals to calculate the dose and volume of the drug morphine that 
should be administered to pediatric patients. The results of tests 
with the use of the program, when compared to calculations made 
on paper, are seen as promising concerning the development of 
guidelines to other opiates, so as to ensure the provision of drug 
therapy for patients18.
The educational aspects should not be neglected concerning 
prevention of ME with HAM. Nurses need and expect to have a 
permanent education program on the safe administration of these 
medications7, approaching the medications' action in the physio-
logical level and their relation to disease, appropriate techniques 
for preparation and administration, and also the choice of specific 
material and technological resources for safe practices14.
The prevention of any adverse event is fundamental regarding 
the management of the system of medication use. All professionals 
involved in assistance should feel responsible for guaranteeing the 
quality of the system and the safety of the patient13. The institutions' 
leaders should ensure that the occurrences are informed and 
analyze their causes so that improvements can be made.
The limitation of this study is the fact that the theoretical 
institutional framework was utilized in the distribution of the me-
dication classes, hindering comparisons with other national or 
international studies.
CONCLUSION
It was verified that a high number of medications was in-
volved in the occurrences, and they were distributed among 33 
classes according to their predominant action. The majority of 
the occurrences was related to the class of antibiotics, gastric 
acid reducers and antihypertensive drugs. As the studied unit 
was a general ICU, with diverse admission diagnoses, severe 
pathologies and severe health conditions of the patients, the 
classes of the involved medications indicate fragility in the 
subsystems of distribution and administration, negatively affecting 
the result of the assistance provided for the patient, a situation 
that deserves close attention from managers.
Occurrences with HAM were identified and corresponded 
to five classes. The class of venous anesthetics was the predo-
minant one, confirming that the use of this type of medication is 
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frequent and that they are involved in errors, reiterating the need 
of intense monitoring of the patient at the ICU and educational 
practices for the assistance team.
It is expected that further studies are conducted on the 
theme, so as to compare interventions in structural and procedural 
conditions and their impacts on the number of ME and their 
consequences to the patient.
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